Member: Andrzej…
Member: Andrzej CzeslawskiAlternate: Pawel Pawlowski Office for Registration of Medicinal Products, Medical Devices and Biocidal ProductsAl. Jerozolimskie 181CPL-02-222 Warszawa
Member: Marta…
Member: Marta Marcelino Alternate: Rui Pedro da Costa Vilar INFARMEDParque de Saúde de LisboaAvenida do Brasil, n° 53PT-1700 LISBOA
Member: Christin…
Member: Christin OlofssonAlternate: Adam Andersson Medical Products AgencyDag Hammarskjölds väg 42SE-751237 UPPSALA
Member: Vlasta Zavadova Office of…
Member: Vlasta Zavadova Office of HealthÄulestrasse 51LI-9490 Vaduz
ICH Q3E Draft Guideline is Available Now on the ICH Website
The ICH Q3E draft “Guideline for Extractables and Leachables” and supporting document has reached Step 2b of the ICH Process on 1 August 2025 and entered the Step 3 public consultation period.
LevosimendanDate of publication:…
LevosimendanDate of publication: 08/08/2025
WarfarinDate of publication:…
WarfarinDate of publication: 08/08/2025
LactuloseDate of publication:…
LactuloseDate of publication: 08/08/2025
LoperamideDate of publication:…
LoperamideDate of publication: 08/08/2025
LinezolidDate of publication:…
LinezolidDate of publication: 08/08/2025